1Chalhoub N,Baker S J. PTEN and the PI3-kinase pathway in cancer[J].Annu Rev Pathol,2009.127-150.
2López-Knowles E,O'Toole S A,McNeil C M. PI3K pathway activation in breast cancer is associated with the basal-like phenotype and cancer-specific mortality[J].International Journal of Cancer,2010,(05):1121-1131.
3Eng C. PTEN:one gene,many syndromes[J].Human Mutation,2003,(03):183-198.
4Maehama T,Taylor G S,Dixon J E. PTEN and myotubularin:novel phosphoinositide phosphatases[J].Annual Review of Biochemistry,2001.247-279.
5Perren A,Weng L P,Boag A H. Immunohistochemical evidence of loss of PTEN expression in primary ductal adenocarcinomas of the breast[J].American Journal of Pathology,1999,(04):1253-1260.
6Bose S,Wang S I,Terry M B. Allelic loss of chromosome 10q23 is associated with tumor progression in breast carcinomas[J].Oncogene,1998,(01):123-127.
7Bose S,Chandran S,Mirocha J M. The Akt pathway in human breast cancer:a tissue-array-based analysis[J].Modern Pathology,2006,(02):238-245.
8Saal L H,Johansson P,Holm K. Poor prognosis in carcinoma is associated with a gene expression signature of aberrant PTEN tumor suppressor pathway activity[J].Proceedings of the National Academy of Sciences(USA),2007,(18):7564-7569.
9Loi S,Haibe-Kains B,Majjaj S. PIK3CA mutations associated with gene signature of low mTORC1 signaling and better outcomes in estrogen receptor-positive breast cancer[J].Proceedings of the National Academy of Sciences(USA),2010,(22):10208-10213.
10Chung M J,Jung S H,Lee B J. Inactivation of the PTEN gene protein product is associated with the invasiveness and metastasis,but not angiogenesis,of breast cancer[J].Pathology International,2004,(01):10-15.
同被引文献52
1Rubinfeld H1Shimon I.PI3K/Akt/mTOR and Raf/MEK/ERK signaling pathways perturbations in non-functioning pituitary adenomas[J].Endocrine,2012,42(2):285-291.
2Siegel R, Ma J, Zou Z, et al. Cancer sta-tistics, 2014[J]. CA Cancer J Clin, 2014, 64(1): 9-29.
3Sabine VS, Crozier C, Brookes CL, et al. Mutational analysis of pi3k/akt signaling pathway in tamoxifenexemestane adjuvant multinational pathology study[J]. J Clin Oncol, 2014, 32(27): 2951-2958.
4Harder H, Langridge C, Solis-Trapala 1, et al. Post-operative exercises after breast cancer surgery: results of a RCT evaluating standard care versus standard care plus additional yoga exercise[J]. European Journal of Integrative Medicine, 2015,56:157-186.
5Aceto N, Bardia A, Miyamoto DT, et al. Circulating tumor cell clusters are oligoelonal precursors of breast cancer metastasis[J]. Ce[1, 2014, 158(5): 1110-1122.
6Saini KS, Loi S, de Azambuja A, et al. Targeting the pi3k/ Akt/mtor and Raf/mek/erk pathways in the treatment of breast cancer[J]. Cancer Treat Rev, 2013, 39(8): 935-946.
7Boosani CS, Agrawal DK. PTEN modulators: a patent review[J]. Expert Opin Ther Pat, 2013, 23(5): 569-580.
8Wikman H, Lamszus K, Detels N, et al. Relevance of PTEN loss in brain metastasis formation in breast cancer patients[J]. Breast Cancer Res, 2012, 14(2): R49.
9Hurvitz SA, Hu Y, O'Brien N, et al. Current approaches and future directions in the treatment of HER2-positive breast cancer[J]. Cancer Treat Rev, 2013, 39(3): 219-229.
